Search

Your search keyword '"Asselbergs, F. W."' showing total 423 results

Search Constraints

Start Over You searched for: Author "Asselbergs, F. W." Remove constraint Author: "Asselbergs, F. W."
423 results on '"Asselbergs, F. W."'

Search Results

2. Electrocardiogram-based mortality prediction in patients with COVID-19 using machine learning

3. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

6. The plasma proteome is linked with left ventricular and left atrial function parameters in patients with chronic heart failure.

7. Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST)

8. Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial

10. The plasma proteome is linked with left ventricular and left atrial function parameters in patients with chronic heart failure

11. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis

13. BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status

15. Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial

16. The plasma proteome is linked with left ventricular and left atrial function parameters in patients with chronic heart failure

17. The plasma proteome is linked with left ventricular and left atrial function parameters in patients with chronic heart failure

18. Influence of stressful life events and personality traits on PLN cardiomyopathy severity:an exploratory study

19. Influence of stressful life events and personality traits on PLN cardiomyopathy severity: an exploratory study

21. ONCOR: design of the Dutch cardio-oncology registry

23. Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations

25. A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure: Design and rationale of the MONITOR HF multicentre randomised clinical trial

26. The added value of abnormal regional myocardial function for risk prediction in arrhythmogenic right ventricular cardiomyopathy

27. Echocardiographic deformation imaging as a substitute for cardiac magnetic resonance imaging in arrhythmogenic right ventricular cardiomyopathy risk prediction

36. Circadian rhythms in pump parameters of patients on contemporary left ventricular assist device support

37. Circadian rhythms in pump parameters of patients on contemporary left ventricular assist device support

38. Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity:an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers

39. Circadian rhythms in pump parameters of patients on contemporary left ventricular assist device support

40. Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers

41. Prognostic value of strain by feature-tracking cardiac magnetic resonance in arrhythmogenic right ventricular cardiomyopathy

42. Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease

45. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

46. Dilated Cardiomyopathy – Results, Conclusions and Perspectives

48. Longitudinal validation of the phospholamban (PLN) p.Arg14del risk model

49. The effect of eplerenone on the disease onset and progression of phospholamban cardiomyopathy in presymptomatic mutation carriers: results of the i-PHORECAST trial

Catalog

Books, media, physical & digital resources